Skip to main content

Table 2 Immune check point inhibitors, Treatment response in solid cancer

From: The effect of antibiotics on the clinical outcomes of patients with solid cancers undergoing immune checkpoint inhibitor treatment: a retrospective study

 TotalATBno ATBp value TotalATBno ATBp value
CR0000.034OR44 (21%)12 (14%)32 (26%)0.038
PR44 (21%)12 (14%)32 (26%) nOR166 (79%)74 (86%)92 (74%) 
SD83 (39.5%)32 (37%)51 (41%) DC127 (60%)44 (51%)83 (67%)0.022
PD83 (39.5%)42 (49%)41 (33%) nDC83 (40%)42 (49%)41 (33%) 
Total21086124 Total21086124 
  1. Non-evaluated, N = 24
  2. ATB Antibiotics